BridgeMD
New treatment option for Rectal Cancer, Radiotherapy
Official title Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
ClinicalTrials.gov ID: NCT06837831
What this study is testing
What is Experimental group?
Experimental group is an investigational medicine, being studied as a potential treatment for rectal cancer, radiotherapy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Background: According to GLOBOCAN 2022 statistics, colorectal cancer has become the third most common cancer disease worldwide, and also the second leading cause of death. The incidence rate of rectal cancer is particularly prominent.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Confirmed rectal cancer by histopathological diagnosis;
- Individuals with clear indications for radiotherapy;
- Individuals who receive radiation therapy for the first time and develop grade 2 or higher acute radiation dermatitis after receiving radiation...
- Age ≥ 18 years old;
- Those who voluntarily participate in this study and sign the informed consent form.
You likely can't join if
- Individuals with allergic constitution and allergies to the drugs and materials used in this study;
- Those who withdraw or interrupt radiotherapy midway;
- Individuals with mental illness, emotional instability, or inability to express their own feelings;
- Individuals with various comorbidities such as serious cardiovascular and cerebrovascular diseases, digestive system diseases, hematological...
- Physical condition score (Eastern Cooperative Oncology Group, ECOG) \>3 points;
- Individuals suffering from anal fissures and other diseases that cause skin damage to the anal canal;
See the full eligibility criteria
- Confirmed rectal cancer by histopathological diagnosis;
- Individuals with clear indications for radiotherapy;
- Individuals who receive radiation therapy for the first time and develop grade 2 or higher acute radiation dermatitis after receiving radiation therapy;
- Age ≥ 18 years old;
- Those who voluntarily participate in this study and sign the informed consent form.
- Individuals with allergic constitution and allergies to the drugs and materials used in this study;
- Those who withdraw or interrupt radiotherapy midway;
- Individuals with mental illness, emotional instability, or inability to express their own feelings;
- Individuals with various comorbidities such as serious cardiovascular and cerebrovascular diseases, digestive system diseases, hematological diseases, and infectious diseases;
- Physical condition score (Eastern Cooperative Oncology Group, ECOG) \>3 points;
- Individuals suffering from anal fissures and other diseases that cause skin damage to the anal canal;
- Individuals with an artificial anus.
The study team makes the final eligibility decision.
Where it's taking place
- Jinan, Shandong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinan, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.